Roberto Dina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Roberto Dina has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
M. Gudi
Department of Cellular Pathology; Imperial College NHS Trust; London; UK
3 shared publications- Fernando Schmitt
PerMed Research Group, RISE-Health, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal
2 shared publications G. Kocjan
Department of Cellular Pathology, University College London, UK
2 shared publicationsP. Vielh
Department of Pathology, Institute Gustave Roussy, Villejuif, France
2 shared publications- Adele Savage
Department of Surgery and Cancer, Imperial College London, Du Cane Road, London W12 0NN, UK
1 shared publication - Ala Amgheib
Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK
1 shared publication
Latest Publications
- Open Access
Point-of-Care Diagnosis of Endometrial Cancer Using the Surgical Intelligent Knife (iKnife)—A Prospective Pilot Study of Diagnostic Accuracy
Introduction: Delays in the diagnosis and treatment of endometrial cancer negatively impact patient survival. The aim of this study was to establish whether rapid evaporative ionisation mass spectrometry using the iKnife can accurately distinguish between normal and malignant endometrial biopsy tissue samples in real time, enabling point-of-care (POC) diagnoses. Methods: Pipelle biopsy samples were obtained from consecutive women needing biopsies for clinical reasons. A Waters G2-XS Xevo Q-Tof mass spectrometer was used in conjunction with a modified handheld diathermy (collectively called the ‘iKnife’). Each tissue sample was processed with diathermy, and the resultant surgical aerosol containing ionic lipid species was then analysed, producing spectra. Principal component analyses and linear discriminant analyses were performed to determine variance in spectral signatures. Leave-one-patient-out cross-validation was used to test the diagnostic accuracy. Results: One hundred and fifty patients provided Pipelle biopsy samples (85 normal, 59 malignant, 4 hyperplasia and 2 insufficient), yielding 453 spectra. The iKnife differentiated between normal and malignant endometrial tissues on the basis of differential phospholipid spectra. Cross-validation revealed a diagnostic accuracy of 89% with sensitivity, specificity, positive predictive value and negative predictive value of 85%, 93%, 94% and 85%, respectively. Conclusions: This study is the first to use the iKnife to identify cancer in endometrial Pipelle biopsy samples. These results are highly encouraging and suggest that the iKnife could be used in the clinic to provide a POC diagnosis.
Open AccessPoint-of-Care Diagnosis of Endometrial Cancer Using the Surgical Intelligent Knife (iKnife)—A Prospective Pilot Study of Diagnostic Accuracy
Introduction: Delays in the diagnosis and treatment of endometrial cancer negatively impact patient survival. The aim of this study was to establish whether rapid evaporative ionisation mass spectrometry using the iKnife can accurately distinguish between normal and malignant endometrial biopsy tissue samples in real time, enabling point-of-care (POC) diagnoses. Methods: Pipelle biopsy samples were obtained from consecutive women needing biopsies for clinical reasons. A Waters G2-XS Xevo Q-Tof mass spectrometer was used in conjunction with a modified handheld diathermy (collectively called the ‘iKnife’). Each tissue sample was processed with diathermy, and the resultant surgical aerosol containing ionic lipid species was then analysed, producing spectra. Principal component analyses and linear discriminant analyses were performed to determine variance in spectral signatures. Leave-one-patient-out cross-validation was used to test the diagnostic accuracy. Results: One hundred and fifty patients provided Pipelle biopsy samples (85 normal, 59 malignant, 4 hyperplasia and 2 insufficient), yielding 453 spectra. The iKnife differentiated between normal and malignant endometrial tissues on the basis of differential phospholipid spectra. Cross-validation revealed a diagnostic accuracy of 89% with sensitivity, specificity, positive predictive value and negative predictive value of 85%, 93%, 94% and 85%, respectively. Conclusions: This study is the first to use the iKnife to identify cancer in endometrial Pipelle biopsy samples. These results are highly encouraging and suggest that the iKnife could be used in the clinic to provide a POC diagnosis.
- 27 May 2013
- Published by Wiley in Cytopathology
- Vol. 24 (3) , 150-158
Pancreatobiliary cytology in the multidisciplinary setting
This review article discusses the role of endoscopic ultrasound-guided fine needle aspiration (EUS FNA) cytology in the clinical management of patients with pancreatic tumours in the setting of a multidisciplinary team (MDT). The commonest diagnosis encountered is pancreatic adenocarcinoma, which is seldom diagnosed early enough for surgical resection. Thus, cytology is likely to be the only form of diagnosis in the majority of cases. Nevertheless, about half the lesions discussed at the MDT meeting are lesions other than primary adenocarcinoma and a wide differential diagnosis must be considered in order to identify tumours, including neuroendocrine tumours, that are amenable to surgical resection. Cytology is not always definitive and the diagnosis may be helped by categorizing results according to whether they are malignant, suspicious, atypical/indeterminate, benign or inadequate. Discussion at MDT meetings and correlation with clinical and imaging findings along with review of cytology slides may allow equivocal results to be clarified before treatment is decided. Inadequate cytology results are avoided by rapid on-site evaluation of slides; although this is cost-effective in terms of overall patient care, attendance of cytopathologists on-site may not be feasible. At Imperial College NHS Trust, specially trained biomedical scientists successfully carry out rapid on-site evaluation.
- 27 May 2013
- Published by Wiley in Cytopathology
- Vol. 24 (3) , 150-158
Pancreatobiliary cytology in the multidisciplinary setting
This review article discusses the role of endoscopic ultrasound-guided fine needle aspiration (EUS FNA) cytology in the clinical management of patients with pancreatic tumours in the setting of a multidisciplinary team (MDT). The commonest diagnosis encountered is pancreatic adenocarcinoma, which is seldom diagnosed early enough for surgical resection. Thus, cytology is likely to be the only form of diagnosis in the majority of cases. Nevertheless, about half the lesions discussed at the MDT meeting are lesions other than primary adenocarcinoma and a wide differential diagnosis must be considered in order to identify tumours, including neuroendocrine tumours, that are amenable to surgical resection. Cytology is not always definitive and the diagnosis may be helped by categorizing results according to whether they are malignant, suspicious, atypical/indeterminate, benign or inadequate. Discussion at MDT meetings and correlation with clinical and imaging findings along with review of cytology slides may allow equivocal results to be clarified before treatment is decided. Inadequate cytology results are avoided by rapid on-site evaluation of slides; although this is cost-effective in terms of overall patient care, attendance of cytopathologists on-site may not be feasible. At Imperial College NHS Trust, specially trained biomedical scientists successfully carry out rapid on-site evaluation.
- 22 November 2012
- Published by Wiley in Cytopathology
- Vol. 23 (6) , 349-352
The NHS Cervical Screening Programme criteria for evaluating cervical cytology: comparison of the new with the old
- 22 November 2012
- Published by Wiley in Cytopathology
- Vol. 23 (6) , 349-352
The NHS Cervical Screening Programme criteria for evaluating cervical cytology: comparison of the new with the old
- 18 May 2011
- Published by Wiley in Cytopathology
- Vol. 22 (3) , 209-210
Authors’ response
- 23 March 2011
- Published by Wiley in Cytopathology
- Vol. 22 (2) , 139-140
The danger to cytopathology of over-specialization and its relevance for histopathology
- 23 March 2011
- Published by Wiley in Cytopathology
- Vol. 22 (2) , 139-140
The danger to cytopathology of over-specialization and its relevance for histopathology
- 1 September 2008
- Published by Springer Nature in Virchows Archiv
- Vol. 453 (3) , 307-308
Parathyroid tissue in an adult’s cervical bronchogenic cyst
- 1 September 2008
- Published by Springer Nature in Virchows Archiv
- Vol. 453 (3) , 307-308
Parathyroid tissue in an adult’s cervical bronchogenic cyst
- Open Access
- 3 August 2007
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 147
Case report: PET/CT, a cautionary tale
Background: The use of combined positron emission tomography/computerised tomography (PET/CT) scanners in oncology has been shown to improve the staging of tumours and the detection of relapses. However, mis-registration errors are increasingly recognised to be a common pitfall of PET/CT studies. Case Presentation: We report a patient with a germ cell tumour of the testis, who underwent a PET/CT scan to detect the site of relapse with a view to surgical removal. However, the PET/CT scan mislocalised the tumour site to be within the T2 vertebral body. A subsequent endoscopic ultrasound scan however showed the tumour to be anterior to the vertebral body, which was confirmed at surgery. Conclusion: In this report, we highlight the artefactual mislocalisation errors which may occur with PET/CT imaging, and the need to review and verify these scans.
- 3 August 2007
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 147
Open AccessCase report: PET/CT, a cautionary tale
Background: The use of combined positron emission tomography/computerised tomography (PET/CT) scanners in oncology has been shown to improve the staging of tumours and the detection of relapses. However, mis-registration errors are increasingly recognised to be a common pitfall of PET/CT studies. Case Presentation: We report a patient with a germ cell tumour of the testis, who underwent a PET/CT scan to detect the site of relapse with a view to surgical removal. However, the PET/CT scan mislocalised the tumour site to be within the T2 vertebral body. A subsequent endoscopic ultrasound scan however showed the tumour to be anterior to the vertebral body, which was confirmed at surgery. Conclusion: In this report, we highlight the artefactual mislocalisation errors which may occur with PET/CT imaging, and the need to review and verify these scans.